Mazzei Maria Antonietta, Guerrini Susanna, Gentili Francesco, Galzerano Giuseppe, Setacci Francesco, Benevento Domenico, Mazzei Francesco Giuseppe, Volterrani Luca, Setacci Carlo
Maria Antonietta Mazzei, Susanna Guerrini, Francesco Gentili, Luca Volterrani, Department of Medical, Surgical and Neuro Sciences, Diagnostic Imaging, University of Siena, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.
World J Radiol. 2017 Jul 28;9(7):304-311. doi: 10.4329/wjr.v9.i7.304.
To validate the feasibility of high resolution computed tomography (HRCT) of the lung prior to computed tomography angiography (CTA) in assessing incidental thoracic findings during endovascular aortic aneurysm repair (EVAR) planning or follow-up.
We conducted a retrospective study among 181 patients (143 men, mean age 71 years, range 50-94) referred to our centre for CTA EVAR planning or follow-up. HRCT and CTA were performed before or after 1 or 12 mo respectively to EVAR in all patients. All HRCT examinations were reviewed by two radiologists with 15 and 8 years' experience in thoracic imaging. The results were compared with histology, bronchoscopy or follow-up HRCT in 12, 8 and 82 nodules respectively.
There were a total of 102 suspected nodules in 92 HRCT examinations, with a mean of 1.79 nodules per patient and an average diameter of 9.2 mm (range 4-56 mm). Eighty-nine out of 181 HRCTs resulted negative for the presence of suspected nodules with a mean smoking history of 10 pack-years (p-y, range 5-18 p-y). Eighty-two out of 102 (76.4%) of the nodules met criteria for computed tomography follow-up, to exclude the malignant evolution. Of the remaining 20 nodules, 10 out of 20 (50%) nodules, suspected for malignancy, underwent biopsy and then surgical intervention that confirmed the neoplastic nature: 4 (20%) adenocarcinomas, 4 (20%) squamous cell carcinomas, 1 (5%) small cell lung cancer and 1 (5%) breast cancer metastasis); 8 out of 20 (40%) underwent bronchoscopy (8 pneumonia) and 2 out of 20 (10%) underwent biopsy with the diagnosis of sarcoidosis.
HRCT in EVAR planning and follow-up allows to correctly identify patients requiring additional treatments, especially in case of lung cancer.
验证在血管腔内主动脉瘤修复术(EVAR)规划或随访期间,在计算机断层血管造影(CTA)之前进行肺部高分辨率计算机断层扫描(HRCT)以评估偶然发现的胸部病变的可行性。
我们对181例患者(143例男性,平均年龄71岁,范围50 - 94岁)进行了一项回顾性研究,这些患者因CTA EVAR规划或随访被转诊至我们中心。所有患者在EVAR前或分别在1个月或12个月后进行了HRCT和CTA检查。所有HRCT检查均由两位分别具有15年和8年胸部影像学经验的放射科医生进行评估。结果分别与12个、8个和82个结节的组织学、支气管镜检查或随访HRCT结果进行比较。
92次HRCT检查中共发现102个可疑结节,平均每位患者1.79个结节,平均直径9.2毫米(范围4 - 56毫米)。181次HRCT检查中有89次未发现可疑结节,这些患者的平均吸烟史为10包年(p - y,范围5 - 18 p - y)。102个结节中有82个(76.4%)符合计算机断层扫描随访标准,以排除恶性病变进展。其余20个结节中,20个疑似恶性的结节中有10个(50%)接受了活检,随后的手术干预证实了肿瘤性质:4个(20%)腺癌,4个(20%)鳞状细胞癌,1个(5%)小细胞肺癌和1个(5%)乳腺癌转移;20个中有8个(40%)接受了支气管镜检查(8例肺炎),20个中有2个(10%)接受了活检,诊断为结节病。
在EVAR规划和随访中进行HRCT能够正确识别需要额外治疗的患者,尤其是在肺癌患者中。